Cirmtuzumab
Showing 1 - 7 of 7
Metastatic Castration-resistant Prostate Cancer Trial in La Jolla (Cirmtuzumab)
Not yet recruiting
- Metastatic Castration-resistant Prostate Cancer
- Cirmtuzumab
-
La Jolla, CaliforniaUniversity of California San Diego
May 22, 2022
Breast Tumors Trial in La Jolla (Cirmtuzumab + Paclitaxel)
Active, not recruiting
- Breast Neoplasms
- Cirmtuzumab + Paclitaxel
-
La Jolla, CaliforniaUniversity of California, San Diego
May 16, 2022
B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma Trial in United States (Cirmtuzumab (2-16
Recruiting
- B-cell Chronic Lymphocytic Leukemia
- +3 more
- Cirmtuzumab (2-16 kg/mg) plus Ibrutinib
- +5 more
-
Duarte, California
- +12 more
Jun 16, 2022
Chronic Lymphocytic Leukemia Trial in San Diego (Cirmtuzumab, Venetoclax)
Recruiting
- Chronic Lymphocytic Leukemia
- Cirmtuzumab
- Venetoclax
-
San Diego, CaliforniaUCSD Koman Family Outpatient Pavilion
Nov 24, 2021
Lymphoma, Mantle-Cell, Lymphoma, Lymphoproliferative Disorders Trial (Zilovertamab, Ibrutinib, Placebo)
Not yet recruiting
- Lymphoma, Mantle-Cell
- +7 more
- Zilovertamab
- +2 more
- (no location specified)
Jun 21, 2022
Chronic Lymphocytic Leukemia Trial in La Jolla (cirmtuzumab)
Completed
- Chronic Lymphocytic Leukemia
- cirmtuzumab
-
La Jolla, CaliforniaUCSD Moores Cancer Center
Jul 29, 2020
Chronic Lymphocytic Leukemia Trial in La Jolla (cirmtuzumab)
Completed
- Chronic Lymphocytic Leukemia
- cirmtuzumab
-
La Jolla, CaliforniaUC San Diego Moores Cancer Center
Mar 18, 2019